Development of small molecules targeting the pseudokinase Her3
DC Field | Value | Language |
---|---|---|
dc.contributor.author | Lim, Sang Min | - |
dc.contributor.author | Xie, Ting | - |
dc.contributor.author | Westover, Kenneth D. | - |
dc.contributor.author | Ficarro, Scott B. | - |
dc.contributor.author | Tae, Hyun Seop | - |
dc.contributor.author | Gurbani, Deepak | - |
dc.contributor.author | Sim, Taebo | - |
dc.contributor.author | Marto, Jarrod A. | - |
dc.contributor.author | Jaenne, Pasi A. | - |
dc.contributor.author | Crews, Craig M. | - |
dc.contributor.author | Gray, Nathanael S. | - |
dc.date.accessioned | 2021-09-04T13:30:10Z | - |
dc.date.available | 2021-09-04T13:30:10Z | - |
dc.date.created | 2021-06-18 | - |
dc.date.issued | 2015-08-15 | - |
dc.identifier.issn | 0960-894X | - |
dc.identifier.uri | https://scholar.korea.ac.kr/handle/2021.sw.korea/92754 | - |
dc.description.abstract | Her3 is a member of the human epidermal growth factor receptor (EGFR) tyrosine kinase family, and it is often either overexpressed or deregulated in many types of human cancer. Her3 has not been the subject of small-molecule inhibitor development because it is a pseudokinase and does not possess appreciable kinase activity. We recently reported on the development of the first selective irreversible Her3 ligand (TX1-85-1) that forms a covalent bond with cysteine 721 which is unique to Her3 among all kinases. We also developed a bi-functional compound (TX2-121-1) containing a hydrophobic adamantane moiety and the same warhead of TX1-85-1 that is capable of inhibiting Her3-dependent signaling and growth. Here we report on the structure-based medicinal chemistry effort that resulted in the discovery of these two compounds. (C) 2015 Elsevier Ltd. All rights reserved. | - |
dc.language | English | - |
dc.language.iso | en | - |
dc.publisher | PERGAMON-ELSEVIER SCIENCE LTD | - |
dc.subject | TYROSINE KINASE | - |
dc.subject | EXTENDED 5-SUBSTITUENT | - |
dc.subject | SELECTIVE INHIBITORS | - |
dc.subject | LUNG-CANCER | - |
dc.subject | PROTEIN | - |
dc.subject | POTENT | - |
dc.subject | DOMAIN | - |
dc.subject | ERBB3 | - |
dc.subject | DEGRADATION | - |
dc.subject | DISCOVERY | - |
dc.title | Development of small molecules targeting the pseudokinase Her3 | - |
dc.type | Article | - |
dc.contributor.affiliatedAuthor | Sim, Taebo | - |
dc.identifier.doi | 10.1016/j.bmcl.2015.04.103 | - |
dc.identifier.wosid | 000357572000062 | - |
dc.identifier.bibliographicCitation | BIOORGANIC & MEDICINAL CHEMISTRY LETTERS, v.25, no.16, pp.3382 - 3389 | - |
dc.relation.isPartOf | BIOORGANIC & MEDICINAL CHEMISTRY LETTERS | - |
dc.citation.title | BIOORGANIC & MEDICINAL CHEMISTRY LETTERS | - |
dc.citation.volume | 25 | - |
dc.citation.number | 16 | - |
dc.citation.startPage | 3382 | - |
dc.citation.endPage | 3389 | - |
dc.type.rims | ART | - |
dc.type.docType | Article | - |
dc.description.journalClass | 1 | - |
dc.description.journalRegisteredClass | scie | - |
dc.description.journalRegisteredClass | scopus | - |
dc.relation.journalResearchArea | Pharmacology & Pharmacy | - |
dc.relation.journalResearchArea | Chemistry | - |
dc.relation.journalWebOfScienceCategory | Chemistry, Medicinal | - |
dc.relation.journalWebOfScienceCategory | Chemistry, Organic | - |
dc.subject.keywordPlus | TYROSINE KINASE | - |
dc.subject.keywordPlus | EXTENDED 5-SUBSTITUENT | - |
dc.subject.keywordPlus | SELECTIVE INHIBITORS | - |
dc.subject.keywordPlus | LUNG-CANCER | - |
dc.subject.keywordPlus | PROTEIN | - |
dc.subject.keywordPlus | POTENT | - |
dc.subject.keywordPlus | DOMAIN | - |
dc.subject.keywordPlus | ERBB3 | - |
dc.subject.keywordPlus | DEGRADATION | - |
dc.subject.keywordPlus | DISCOVERY | - |
dc.subject.keywordAuthor | Her3 | - |
dc.subject.keywordAuthor | Pseudokinase | - |
dc.subject.keywordAuthor | Hydrophobic tagging | - |
dc.subject.keywordAuthor | Cancer | - |
dc.subject.keywordAuthor | Pyrazolopyrimidine | - |
Items in ScholarWorks are protected by copyright, with all rights reserved, unless otherwise indicated.
(02841) 서울특별시 성북구 안암로 14502-3290-1114
COPYRIGHT © 2021 Korea University. All Rights Reserved.
Certain data included herein are derived from the © Web of Science of Clarivate Analytics. All rights reserved.
You may not copy or re-distribute this material in whole or in part without the prior written consent of Clarivate Analytics.